Ian Ganley, PhD, obtained his undergraduate and Master’s degree in biochemistry from the University of Oxford in 1997, and after working for one year at Oxford Glycosciences Ltd., moved to the University of Cambridge to undertake a PhD on the lipid hydrolase phospholipase D1. In 2002, he moved to Stanford University, where he carried out postdoctoral research to decipher the role of Rab proteins in intracellular transport. During this time he became interested in the cellular process of autophagy and joined the laboratory of Dr. Xuejun Jiang at Memorial Sloan-Kettering Cancer Center in New York to understand this further. Dr. Ganley relocated to Dundee in August 2010 to establish his research group in the MRC PPU, and became a tenured programme leader in 2016. He is the developer of the "mito-QC" mitophagy reporter mouse model and a world leader in animal studies of mitophagy as related to Parkinson’s disease.